MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of marketable...
$51,875K
Proceeds from exercise of
stock options
$203K
Net cash provided by
(used in) investing...
$17,051K
Net cash provided by
financing activities
$203K
Canceled cashflow
$34,824K
Net increase in
cash, cash...
-$331K
Canceled cashflow
$17,254K
Stock-based compensation
$4,601K
Prepaid expenses and
other assets
-$1,943K
Amortization of right-of-use
assets - operating
$268K
Accounts payable
$101K
Depreciation
$58K
Interest income
$7,088K
Purchases of marketable
securities,...
$34,774K
Purchases of property and
equipment
$50K
Net cash used in
operating activities
-$17,508K
Canceled cashflow
$6,971K
Effect of exchange
rates on cash, cash...
-$77K
something is missing
$54,427K
Total other (income)
expense
$7,048K
Canceled cashflow
$40K
Net loss
-$22,829K
Canceled cashflow
$61,475K
Accretion of marketable
securities, net
-$1,063K
Accrued expenses
-$317K
Operating lease
liabilities
-$270K
Other expense
-$40K
Loss from operations
-$84,304K
Total operating
expenses
$84,304K
Back
Back
Cash Flow
source: myfinsight.com
Ventyx Biosciences, Inc. (VTYX)
Ventyx Biosciences, Inc. (VTYX)